Press Release: BigBear.ai Announces Fourth Quarter, And Full Year 2024 Results, And Provides 2025 Outlook

Dow Jones
07 Mar

BigBear.ai Announces Fourth Quarter, And Full Year 2024 Results, And Provides 2025 Outlook

   -- 4Q 24 revenue of $43.8 million (4Q 23 $40.6 million) +8% year-over-year 
 
   -- Exchanged $182.3 million in 6.00% convertible senior notes due in 2026 
      for 6.00% convertible senior secured notes due in 2029; $58 million has 
      already converted into equity since the end of 4Q 24 resulting in $142.3 
      million remaining debt on convertible notes. 
 
   -- Cash balance of $50.1 million, as of December 31, 2024; During 1Q 25, 
      received gross proceeds of $64.7 million of cash, following the exercise 
      of previously issued warrants; combined with $58 million of conversions 
      on convertible debt, net debt 1 has decreased from $150 million to $27 
      million and debt-to-cash ratio 2 has decreased from 4.0 to 1.2 since the 
      end of 4Q 24. 
 
   -- 2025 Outlook provided between $160 million - $180 million revenue, and 
      negative single digit Adjusted EBITDA* 
MCLEAN, Va.--(BUSINESS WIRE)--March 06, 2025-- 

BigBear.ai Holdings, Inc. (NYSE: BBAI) ("BigBear.ai" or the "Company"), a leader in AI-powered decision intelligence solutions, today announced financial results for the fourth quarter of 2024 and issued an investor presentation that has been posted to the Investor Relations section of the Company's website.

"2024 was a pivotal year for the business. We demonstrated momentum through major contract wins, expanding our backlog and growing our pipeline, maturing our technology portfolio, and restructuring our debt to strengthen our financial position for the long term. These efforts were driven by strong execution from our team," said Kevin McAleenan, Chief Executive Officer, BigBear.ai.

"On the financial front, we've kicked off the first quarter of 2025 by significantly deleveraging our balance sheet. Through a combination of cash proceeds from warrant exercises and debt reductions resulting from conversions on our convertible notes, we're in a strong position for growth in 2025 and beyond," said Julie Peffer, Chief Financial Officer, BigBear.ai.

Financial Highlights

   -- Revenue increased 8% to $43.8 million for the fourth quarter of 2024, 
      compared to $40.6 million for the fourth quarter of 2023 primarily due to 
      additional revenue related to Department of Homeland Security and Digital 
      Identity awards. 
 
   -- Gross margin was 37.4% in the fourth quarter of 2024 as compared to 32.1% 
      in the fourth quarter of 2023, primarily driven by year-end fringe and 
      overhead true-up allocation adjustments in 4Q 24 of $2.7 million with an 
      offsetting increase in SG&A expenses. 
 
   -- Primarily driven by the non-cash changes in fair value of $93.3 million 
      from derivative liabilities related to the 2029 convertible notes and 
      warrants, net loss in the fourth quarter of 2024 was $108.0 million, 
      compared to $21.3 million for the fourth quarter of 2023. 
 
   -- Non-GAAP Adjusted EBITDA* of $2.0 million for the fourth quarter of 2024 
      compared to $3.7 million for the fourth quarter of 2023, primarily driven 
      by increased Recurring SG&A*. 
 
   -- SG&A of $22.2 million for the fourth quarter of 2024 compared to $18.2 
      million for the fourth quarter of 2023 and Recurring SG&A* of $18.0 
      million in the fourth quarter of 2024 compared to $12.3 million in the 
      fourth quarter of 2023. The year-over-year increases include Pangiam's 
      headcount and operating expenses not included in the fourth quarter of 
      2023 as well as year-end fringe and overhead true-up allocation 
      adjustments of $2.7 million in the fourth quarter of 2024 which are 
      offset in improved gross profit. 
 
   -- Ending backlog was $418 million as of December 31, 2024, an increase of 
      $250 million or 2.5x ending backlog as of December 31, 2023. 
 
   -- The consolidated year-to-date results include results from Pangiam from 
      the acquisition date of February 29, 2024 to December 31, 2024. 

Financial Outlook

For the year-ended December 31, 2025, the Company projects:

   -- Revenue between $160 million and $180 million 
 
   -- Adjusted EBITDA* -- negative single digit millions 

In the event that some form of US Government shutdown was to take place in 2025, or a substantial shift in government national security priorities, BigBear.ai would review its guidance as part of prudent financial planning and its efforts to build a long-term sustainable business.

The above information on Outlook, and other sections of this release contain forward-looking statements, which are based on the Company's current expectations. Actual results may differ materially from those projected. It is the Company's practice not to incorporate adjustments into its financial outlook for proposed acquisitions, divestitures, changes in law, or new accounting standards until such items have been consummated, enacted, or adopted, as the case may be. For additional factors that may impact the Company's actual results, refer to the "Forward-Looking Statements" section in this release.

 
_______________________________________ 
(1)   Net Debt is defined as principal outstanding on convertible notes, less 
      cash and cash equivalents. 
(2)   Debt-to-Cash Ratio is defined as principal outstanding on convertible 
      notes divided by cash and cash equivalents. 
 
 
*Adjusted EBITDA is a non-GAAP financial measure. See the "Non-GAAP Financial 
Measures" section in this press release for additional information and a 
reconciliation. 
 
 
 
 
 
            Summary of Results for the Fourth Quarter and Year Ended 
                     December 31, 2024 and December 31, 2023 
                                   (Unaudited) 
 
 
                          Three Months Ended                 Year Ended 
                             December 31,                   December 31, 
                     ----------------------------  ------------------------------ 
$ thousands (expect 
per share amounts)       2024           2023           2024           2023 
-------------------   -----------    -----------    -----------    ----------- 
Revenues             $     43,827   $     40,563   $    158,236   $    155,164 
Cost of revenues           27,422         27,547        113,016        114,563 
-------------------   -----------    -----------    -----------    ----------- 
    Gross margin           16,405         13,016         45,220         40,601 
Operating expenses: 
    Selling, 
     general and 
     administrative        22,243         18,232         80,040         71,057 
    Research and 
     development            2,334          2,031         10,863          5,035 
    Restructuring 
     charges                  (30)            42          1,287            822 
    Transaction 
     expenses                  --          1,284          1,450          2,721 
    Goodwill 
    impairment                 --             --         85,000             -- 
-------------------   -----------    -----------    -----------    ----------- 
Operating loss             (8,142)        (8,573)      (133,420)       (39,034) 
    Interest 
     expense                3,597          3,544         14,244         14,200 
    Net increase in 
     fair value of 
     derivatives           93,317          9,395        108,149          7,424 
    Loss on 
     extinguishment 
     of debt                3,440             --          3,440             -- 
    Other (income) 
     expense                 (475)          (306)        (2,194)          (393) 
-------------------   -----------    -----------    -----------    ----------- 
Loss before taxes        (108,021)       (21,206)      (257,059)       (60,265) 
    Income tax 
     expense                   13             50             35            101 
-------------------   -----------    -----------    -----------    ----------- 
Net loss             $   (108,034)  $    (21,256)  $   (257,094)  $    (60,366) 
-------------------   -----------    -----------    -----------    ----------- 
 
Basic and diluted 
 net loss per 
 share               $      (0.43)  $      (0.14)  $      (1.10)  $      (0.40) 
 
Weighted-average 
shares 
outstanding: 
    Basic             250,575,733    156,818,532    233,604,500    149,234,917 
    Diluted           250,575,733    156,818,532    233,604,500    149,234,917 
-------------------   -----------    -----------    -----------    ----------- 
 
 
 
 
 
 
                    Consolidated Balance Sheets as of 
                  December 31, 2024 and December 31, 2023 
                                (Unaudited) 
 
 
                                           December 31,     December 31, 
$ in thousands                                 2024             2023 
----------------------------------------  --------------  ---------------- 
Assets 
Current assets: 
    Cash and cash equivalents              $     50,141    $     32,557 
    Accounts receivable, less allowance 
     for credit losses                           38,953          21,949 
    Contract assets                                 895           4,822 
    Prepaid expenses and other current 
     assets                                       3,768           4,449 
----------------------------------------      ---------       --------- 
Total current assets                             93,757          63,777 
----------------------------------------      ---------       --------- 
Non-current assets: 
    Property and equipment, net                   1,566             997 
    Goodwill                                    119,081          48,683 
    Intangible assets, net                      119,119          82,040 
    Right-of-use assets                           9,263           4,041 
    Other non-current assets                        990             372 
----------------------------------------      ---------       --------- 
Total assets                               $    343,776    $    199,910 
----------------------------------------      ---------       --------- 
 
Liabilities and stockholders' equity 
(deficit) 
Current liabilities: 
    Accounts payable                       $      8,455    $     11,038 
    Short-term debt, including current 
     portion of long-term debt                      818           1,229 
    Accrued liabilities                          19,496          16,233 
    Contract liabilities                          2,541             879 
    Current portion of long-term lease 
     liability                                    1,068             779 
    Derivative liabilities                      170,515          37,862 
    Other current liabilities                        73             602 
----------------------------------------      ---------       --------- 
Total current liabilities                       202,966          68,622 
----------------------------------------      ---------       --------- 
Non-current liabilities: 
    Long-term debt, net                         134,287         194,273 
    Long-term lease liability                     9,120           4,313 
    Deferred tax liabilities                         --              37 
----------------------------------------      ---------       --------- 
Total liabilities                               346,373         267,245 
----------------------------------------      ---------       --------- 
Stockholders' equity (deficit): 
    Common stock, par value $0.0001; 
     500,000,000 shares authorized and 
     251,554,378 shares issued and 
     outstanding at December 31, 2024 
     and 157,287,522 shares issued and 
     outstanding at December 31, 2023                26              17 
    Additional paid-in capital                  625,130         303,428 
    Treasury stock, at cost 9,952,803 
     shares at December 31, 2024 and 
     December 31, 2023                          (57,350)        (57,350) 
    Accumulated deficit                        (570,524)       (313,430) 
----------------------------------------      ---------       --------- 
    Accumulated other comprehensive 
    income                                          121              -- 
----------------------------------------      ---------       --------- 
Total stockholders' equity (deficit)             (2,597)        (67,335) 
Total liabilities and stockholders' 
 equity (deficit)                          $    343,776    $    199,910 
----------------------------------------      ---------       --------- 
 
 
 
 
 
 
     Consolidated Statements of Cash Flows for the Year Ended 
              December 31, 2024 and December 31, 2023 
                            (Unaudited) 
 
 
                      Three Months Ended          Year Ended 
                          December 31,            December 31, 
                     ---------------------  ----------------------- 
$ in thousands          2024       2023        2024       2023 
-------------------   --------    -------    --------    ------- 
Cash flows from 
operating 
activities: 
Net loss             $(108,034)  $(21,256)  $(257,094)  $(60,366) 
Adjustments to 
reconcile net loss 
to net cash used in 
operating 
activities: 
    Depreciation 
     and 
     amortization 
     expense             3,133      1,965      11,873      7,901 
    Amortization of 
     debt issuance 
     costs                 508        506       2,025      2,018 
    Equity-based 
     compensation 
     expense             5,053      6,079      21,127     18,671 
    Goodwill 
    impairment              --         --      85,000         -- 
    Non-cash lease 
     expense               167        147         720        597 
    Provision for 
     doubtful 
     accounts                8        132         228      1,739 
    Deferred income 
     tax (benefit) 
     expense                --         35         (37)        88 
    Loss on 
     extinguishment 
     of debt             3,440         --       3,440         -- 
    Net increase 
     (decrease) in 
     fair value of 
     derivatives        93,317      9,395     108,149      7,424 
    Loss on sale of 
     property and 
     equipment              --         --          --         10 
Changes in assets 
and liabilities: 
    (Increase) 
     decrease in 
     accounts 
     receivable         (6,357)     6,949     (11,753)     6,403 
    Decrease 
     (increase) in 
     contract 
     assets                849     (4,370)      3,927     (3,510) 
    Decrease 
     (increase) in 
     prepaid 
     expenses and 
     other assets          536       (282)      2,076      5,899 
    (Decrease) 
     increase in 
     accounts 
     payable             4,197      1,962      (4,027)    (4,384) 
    (Decrease) 
     increase in 
     accrued 
     liabilities       (10,483)       602      (2,873)     2,637 
    Increase 
     (decrease) in 
     contract 
     liabilities            28     (1,441)        514     (1,143) 
    (Decrease) 
     increase in 
     other 
     liabilities        (1,168)      (497)     (1,414)    (2,291) 
-------------------   --------    -------    --------    ------- 
Net cash used in 
 operating 
 activities            (14,806)       (74)    (38,119)   (18,307) 
-------------------   --------    -------    --------    ------- 
Cash flows from 
investing 
activities: 
    Acquisition of 
    business, net 
    of cash 
    acquired                --         --      13,935         -- 
    Purchases of 
     property and 
     equipment            (180)        --        (484)        (2) 
    Capitalized 
     software 
     development 
     costs              (3,234)    (1,084)    (10,630)    (3,828) 
-------------------   --------    -------    --------    ------- 
Net cash provided 
 by (used in) 
 investing 
 activities             (3,414)    (1,084)      2,821     (3,830) 
-------------------   --------    -------    --------    ------- 
Cash flows from 
financing 
activities: 
    Proceeds from 
    issuance of 
    shares for 
    exercised RDO 
    and PIPE 
    warrants                --         --      53,809         -- 
    Proceeds from 
     issuance of 
     Private 
     Placement and 
     Registered 
     Direct 
     Offering 
     shares                 --         --          --     50,000 
    Payment of 
     Private 
     Placement and 
     Registered 
     Direct 
     Offering 
     transaction 
     costs                  --         --          --     (5,724) 
    Proceeds from 
     short-term 
     borrowings            817      1,229         817      1,229 
    Repayment of 
     short-term 
     borrowings             --         --      (1,229)    (2,059) 
    Payment of debt 
     issuance costs 
     to third 
     parties              (349)        --        (349)        -- 
    Proceeds from 
     exercise of 
     options               302         --         421         -- 
    Issuance of 
     common stock 
     upon ESPP 
     purchase              760        645       1,367      1,176 
    Payments of tax 
     withholding 
     from the 
     issuance of 
     common stock          765       (343)     (2,378)    (2,560) 
-------------------   --------    -------    --------    ------- 
Net cash provided 
 by financing 
 activities              2,295      1,531      52,458     42,062 
-------------------   --------    -------    --------    ------- 
Effect of foreign 
 currency rate 
 changes on cash 
 and cash 
 equivalents               482         --         424         -- 
Net increase 
 (decrease) in cash 
 and cash 
 equivalents           (15,443)       373      17,584     19,925 
Cash and cash 
 equivalents at the 
 beginning of 
 period                 65,584     32,184      32,557     12,632 
-------------------   --------    -------    --------    ------- 
Cash and cash 
 equivalents at the 
 end of the period   $  50,141   $ 32,557   $  50,141   $ 32,557 
-------------------   --------    -------    --------    ------- 
 
 
 
 
 
 
 EBITDA* and Adjusted EBITDA* for the Fourth Quarter and Year Ended 
               December 31, 2024 and December 31, 2023 
                             (Unaudited) 
 
 
                       Three Months Ended          Year Ended 
                           December 31,            December 31, 
                      ---------------------  ----------------------- 
$ thousands              2024       2023        2024       2023 
--------------------   --------    -------    --------    ------- 
Net loss              $(108,034)  $(21,256)  $(257,094)  $(60,366) 
Interest expense          3,597      3,544      14,244     14,200 
Interest income            (486)      (306)     (2,293)      (392) 
Income tax expense 
 (benefit)                   13         50          35        101 
Depreciation and 
 amortization             3,132      1,965      11,872      7,901 
--------------------   --------    -------    --------    ------- 
EBITDA                 (101,778)   (16,003)   (233,236)   (38,556) 
Adjustments: 
    Equity-based 
     compensation         5,053      6,079      21,127     18,671 
    Employer payroll 
     taxes related 
     to equity-based 
     compensation(1)        244         75         985        440 
    Net increase in 
     fair value of 
     derivatives(2)      93,317      9,395     108,149      7,424 
    Restructuring 
     charges(3)             (30)        42       1,287        822 
    Non-recurring 
     strategic 
     initiatives(4)       1,517        545       6,459      3,025 
    Non-recurring 
     litigation(5)           23      2,250       1,142      2,250 
    Transaction 
     expenses(6)             --      1,284       1,450      2,721 
    Non-recurring 
     integration 
     costs(7)               175         --       1,800         -- 
    Goodwill 
    impairment(8)            --         --      85,000         -- 
    Loss on 
     extinguishment 
     of debt(9)           3,440         --       3,440         -- 
--------------------   --------    -------    --------    ------- 
Adjusted EBITDA       $   1,961   $  3,667   $  (2,397)  $ (3,203) 
--------------------   --------    -------    --------    ------- 
 
 
(1)   Includes employer payroll taxes due upon the vesting of equity awards 
      granted to employees. 
(2)   The increase in fair value of derivatives during the year ended December 
      31, 2024, relates to the $42.3 million loss recorded upon the exercise 
      of the 2023 RDO and 2023 PIPE Warrants (the "2023 Warrants") and 
      issuance of the warrants in 2024 (the "2024 Warrants") in connection 
      with the warrant exercise agreements entered into on February 27, 2024 
      and March 4, 2024. The additional loss relates to $(11.4) million fair 
      market value adjustment of the 2024 Warrants and IPO Warrants during the 
      year ended December 31, 2024. This loss is net of a $10.6 million gain 
      related to the issuance of the 2024 Warrants and was further offset by a 
      reduction of $(11.4) million upon remeasurement of the 2024 Warrants and 
      IPO Warrants' fair value during the year ended December 31, 2024. 
      Additionally, for the year-ended December 31, 2024, $54.4 million is 
      related to derivative liabilities in connection with the 2029 
      Convertible Notes. The increase in fair value of derivatives during the 
      year ended December 31, 2023 primarily relates to changes in the fair 
      value of PIPE warrant and RDO warrants issued during the first and 
      second quarters of 2023. 
(3)   During the year ended December 31, 2024 and the year ended December 31, 
      2023, the Company incurred employee separation costs associated with a 
      strategic review of the Company's capacity and future projections to 
      better align the organization and cost structure and improve the 
      affordability of its products and services. 
(4)   Non-recurring professional fees related to the execution of certain 
      strategic initiatives of the Company. 
(5)   Non-recurring litigation consists primarily of legal settlements and 
      related fees for specific proceedings that we have determined arise 
      outside of the ordinary course of business based on the following 
      considerations which we assess regularly: (1) the frequency of similar 
      cases that have been brought to date, or are expected to be brought 
      within two years; (2) the complexity of the case; (3) the nature of the 
      remedy(ies) sought, including the size of any monetary damages sought; 
      (4) offensive versus defensive posture of us; (5) the counterparty 
      involved; and (6) our overall litigation strategy. 
(6)   Transaction expenses during the year ended December 31, 2024 and 
      December 31, 2023 consist primarily of diligence, legal and other 
      related expenses incurred associated with the Pangiam acquisition. 
      Transaction costs incurred in 2022 are primarily related to our 
      acquisition of ProModel Corporation as well as costs associated with 
      evaluating other acquisition opportunities. 
(7)   Non-recurring internal integration costs related to the Pangiam 
      acquisition. 
(8)   During the year ended December 31, 2024, the Company recognized a 
      non-cash goodwill impairment charge primarily driven by a decrease in 
      share price during the quarter compared to the share price of the equity 
      issued as consideration for the purchase of Pangiam. 
(9)   Loss on extinguishment of debt is related to the exchange of the 6.00% 
      convertible senior notes due in 2026 for 6.00% convertible senior 
      secured notes due in 2029. 
 
 
*EBITDA and Adjusted EBITDA are non-GAAP financial measures. See the "Non-GAAP 
Financial Measures" section in this press release for additional information 
and a reconciliation. 
 
 
 
 
 
 
     Adjusted EBITDA Reconciliation* for the Fourth Quarter and Year Ended 
                     December 31, 2024 and December 31, 2023 
                                   (Unaudited) 
 
 
                            Three Months Ended               Year Ended 
                                December 31,                 December 31, 
                        ---------------------------  --------------------------- 
$ in thousands             2024          2023           2024          2023 
                         --------       -------       --------       ------- 
Revenue                 $  43,827      $ 40,563      $ 158,236      $155,164 
 
Net loss                 (108,034)      (21,256)      (257,094)      (60,366) 
Interest expense            3,597         3,544         14,244        14,200 
Interest income              (486)         (306)        (2,293)         (392) 
Income tax expense             13            50             35           101 
Depreciation & 
 amortization               3,132         1,965         11,872         7,901 
----------------------   --------       -------       --------       ------- 
EBITDA                  $(101,778)     $(16,003)     $(233,236)     $(38,556) 
 
Adjustments: 
---------------------- 
    Equity-based 
     compensation           5,053         6,079         21,127        18,671 
    Employer payroll 
     taxes related to 
     equity-based 
     compensation(1)          244            75            985           440 
    Net increase in 
     fair value of 
     derivatives(2)        93,317         9,395        108,149         7,424 
    Restructuring 
     charges(3)               (30)           42          1,287           822 
    Non-recurring 
     integration costs 
     and strategic 
     initiatives(4)(7)      1,692           545          8,259         3,025 
    Non-recurring 
     litigation(5)             23         2,250          1,142         2,250 
    Transaction 
     expenses(6)               --         1,284          1,450         2,721 
    Goodwill 
    impairment(8)              --            --         85,000            -- 
    Loss on 
     extinguishment of 
     debt(9)                3,440            --          3,440            -- 
----------------------   --------       -------       --------       ------- 
Adjusted EBITDA         $   1,961      $  3,667      $  (2,397)     $ (3,203) 
Gross Margin                 37.4%         32.1%          28.6%         26.2% 
Net Loss Margin            (246.5)%       (52.4)%       (162.5)%       (38.9)% 
Adjusted EBITDA Margin        4.5%          9.0%          (1.5)%        (2.1)% 
----------------------   --------       -------       --------       ------- 
 
 
(1)   Includes employer payroll taxes due upon the vesting of equity awards 
      granted to employees. 
(2)   The increase in fair value of derivatives during the year ended December 
      31, 2024, relates to the $42.3 million loss recorded upon the exercise 
      of the 2023 RDO and 2023 PIPE Warrants (the "2023 Warrants") and 
      issuance of the warrants in 2024 (the "2024 Warrants") in connection 
      with the warrant exercise agreements entered into on February 27, 2024 
      and March 4, 2024. The additional loss relates to $(11.4) million fair 
      market value adjustment of the 2024 Warrants and IPO Warrants during the 
      year ended December 31, 2024. This loss is net of a $10.6 million gain 
      related to the issuance of the 2024 Warrants and was further offset by a 
      reduction of $(11.4) million upon remeasurement of the 2024 Warrants and 
      IPO Warrants' fair value during the year ended December 31, 2024. 
      Additionally, for the year-ended December 31, 2024, $54.4 million is 
      related to derivative liabilities in connection with the 2029 
      Convertible Notes. The increase in fair value of derivatives during the 
      year ended December 31, 2023 primarily relates to changes in the fair 
      value of PIPE warrant and RDO warrants issued during the first and 
      second quarters of 2023. 
(3)   During the year ended December 31, 2024 and the year ended December 31, 
      2023, the Company incurred employee separation costs associated with a 
      strategic review of the Company's capacity and future projections to 
      better align the organization and cost structure and improve the 
      affordability of its products and services. 
(4)   Non-recurring professional fees related to the execution of certain 
      strategic initiatives of the Company. 
(5)   Non-recurring litigation consists primarily of legal settlements and 
      related fees for specific proceedings that we have determined arise 
      outside of the ordinary course of business based on the following 
      considerations which we assess regularly: (1) the frequency of similar 
      cases that have been brought to date, or are expected to be brought 
      within two years; (2) the complexity of the case; (3) the nature of the 
      remedy(ies) sought, including the size of any monetary damages sought; 
      (4) offensive versus defensive posture of us; (5) the counterparty 
      involved; and (6) our overall litigation strategy. 
(6)   Transaction expenses during the year ended December 31, 2024 and 
      December 31, 2023 consist primarily of diligence, legal and other 
      related expenses incurred associated with the Pangiam acquisition. 
      Transaction costs incurred in 2022 are primarily related to our 
      acquisition of ProModel Corporation as well as costs associated with 
      evaluating other acquisition opportunities. 
(7)   Non-recurring internal integration costs related to the Pangiam 
      acquisition. 
(8)   During the year ended December 31, 2024, the Company recognized a 
      non-cash goodwill impairment charge primarily driven by a decrease in 
      share price during the quarter compared to the share price of the equity 
      issued as consideration for the purchase of Pangiam. 
(9)   Loss on extinguishment of debt is related to the exchange of the 6.00% 
      convertible senior notes due in 2026 for 6.00% convertible senior 
      secured notes due in 2029. 
 
 
*EBITDA and Adjusted EBITDA are non-GAAP financial measures. See the "Non-GAAP 
Financial Measures" section in this press release for additional information 
and a reconciliation. 
 
 
 
 
 
 
 Recurring SG&A Reconciliation* for the Fourth Quarter and 

(MORE TO FOLLOW) Dow Jones Newswires

March 06, 2025 16:22 ET (21:22 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10